0 NYSE Companies - February 5, 2024Post Holdings Announces Commencement of Senior Secured Notes OfferingST. LOUIS, Feb. 05, 2024 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced it intends […]Read More
0 NYSE Companies - February 5, 2024FTI Consulting to Release Fourth Quarter and Full Year 2023 Results and Host Conference CallWASHINGTON, Feb. 05, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results […]Read More
0 TSX News - February 5, 2024Spectral Medical Provides Early February Tigris Trial Update88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) […]Read More
0 TSX News - February 5, 2024Onex Partners to Invest in Morson GroupTORONTO and MANCHESTER, England, Feb. 05, 2024 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that Onex Partners V has […]Read More
0 TSX Venture News - February 5, 2024Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent OfficeCARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer […]Read More
0 NYSE Companies - February 5, 2024Tyson Foods Reports First Quarter 2024 ResultsSPRINGDALE, Ark., Feb. 05, 2024 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies […]Read More
0 Canadian Stock Exchange News - February 5, 2024MariMed Announces Fourth Quarter and Full Year 2023 Earnings DateNORWOOD, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading […]Read More
0 NASDAQ Companies - February 5, 2024BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)– Accepted with Prescription Drug User Fee Act (PDUFA) action date of November 29, 2024; FDA not currently planning to […]Read More
0 NASDAQ Companies - February 5, 2024Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY® Endovascular Robotic Surgical […]Read More
0 NASDAQ Companies - February 5, 2024Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair CompetitionLawsuit alleges false and misleading advertising and promotion of unapproved cantharidin-containing drugs by Dormer Laboratories in violation of federal and […]Read More